Skanska to construct research laboratory for USD 62 M, about SEK 460 M

Skanska has been contracted to provide construction management services to build a new research center in Pennsylvania, in the US. The contract amounts to USD 62 M, about SEK 460 M, which is included in order bookings for the fourth quarter.

The customer is an American pharmaceutical company.

Skanska has construction management responsibility for the project that comprises new construction of an approximately 14,000-square-meter, four-story building that will house chemistry and biology research labs. The project also includes renovation of an existing structure.

The project totals USD 127 million, SEK 940 million, and the company previously booked USD 65 million, SEK 480 million, in 2004 for the project. Construction is scheduled for completion in June 2010.

Skanska USA Building Inc. is a leading national and local provider of construction, pre-construction consulting, general contracting and design-build services to a broad range of US industries, including life sciences, healthcare, education, high-tech, aviation, transportation, sports and entertainment. Skanska USA Building also provides pharmaceutical validation services to clients. The company is headquartered in Parsippany, New Jersey, and has approximately 3,700 employees. The company reported sales in 2005 of about SEK 30 billion.


For further information please contact:

Tom Crane, Senior Vice President Communication,
Skanska USA Building, tel +1 973 753 3450
Peter Gimbe, Press Officer, Skanska AB, tel +46 8 753 88 99